Company Filing History:
Years Active: 2021
Title: Cristina Tintori: Innovator in Antiproliferative Agents
Introduction
Cristina Tintori is a prominent inventor based in Siena, Italy. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit DDX3, a human helicase. Her work focuses on creating therapeutic agents that can combat viral diseases and other hyperproliferative conditions.
Latest Patents
Cristina Tintori holds 2 patents that showcase her innovative research. The first patent is titled "Use of DDX3 inhibitors as antiproliferative agents." This invention refers to compounds of formula I or II endowed with DDX3 inhibitory activity, relative pharmaceutical compositions, and their use as antihyperproliferative agents. The second patent is "Human helicase DDX3 inhibitors as therapeutic agents." This invention involves compounds endowed with RNA helicase DDX3 inhibitory activity of formula I and II and their therapeutic use, particularly for the treatment of viral diseases.
Career Highlights
Cristina Tintori is affiliated with Azienda Ospedaliera Universitaria Senese, where she conducts her research and development work. Her career is marked by a commitment to advancing medical science through innovative solutions.
Collaborations
Cristina collaborates with esteemed colleagues, including Annalaura Brai and Maurizio Botta. These partnerships enhance her research efforts and contribute to the success of her projects.
Conclusion
Cristina Tintori is a trailblazer in the field of pharmaceutical innovation, with a focus on DDX3 inhibitors. Her patents reflect her dedication to developing effective therapeutic agents. Through her work, she continues to make a significant impact in the medical community.